There's marketing, but there is also a wealth of information from the clinical trials for sofpironium bromide, and whilst there might be a bit of reading there, trial results demonstrate Sofdra's safety, tolerability, and most importantly - its effectiveness! Sofdra is by far the best performing drug for the treatment of axillary hyperhidrosis and dumps all over its competitors. Roll up and roll on people - Sofdra the disruptor!
There's marketing, but there is also a wealth of information...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.020(4.82%) |
Mkt cap ! $789.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.0¢ | 41.5¢ | $3.690M | 8.569M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66897 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 414256 | 15 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |